Program Perspectives in Cell- and Gene-Based Medicines - DGTI
Program Perspectives in Cell- and Gene-Based Medicines - DGTI
Program Perspectives in Cell- and Gene-Based Medicines - DGTI
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>Program</strong> Friday, March 16<br />
Friday, March 16<br />
Scientific Session 7 HZ 4<br />
16:30 - 18:30 <strong>Cell</strong>ular Immune Modulation<br />
Chairs: Harald Klüter, Mannheim; Halvard Bönig, Frankfurt<br />
Inv28<br />
16:30 - 16:50<br />
Inv29<br />
16:50 - 17:10<br />
Inv30<br />
17:10 - 17:30<br />
Or7.1<br />
17:30 - 17:42<br />
Or7.2<br />
17:42 - 17:54<br />
Or7.3<br />
17:54 - 18:06<br />
Or7.4<br />
18:06- 18:18<br />
Or7.5<br />
18:18 - 18:30<br />
T cell antigen receptor therapy<br />
Matthias Theobald, Ma<strong>in</strong>z<br />
Highly purified <strong>and</strong> m<strong>in</strong>imally manipulated cell preparations<br />
for adoptive immunotherapy<br />
Dirk Busch, Munich<br />
Respiratory dendritic cells <strong>in</strong> experimental pneumonia<br />
Holger Hackste<strong>in</strong>, Giessen<br />
Cl<strong>in</strong>ical scale generation <strong>and</strong> functional assessment of<br />
cytok<strong>in</strong>e-<strong>in</strong>duced killer cells aga<strong>in</strong>st acute leukemia <strong>and</strong><br />
soft tissue sarcoma<br />
Eva Rett<strong>in</strong>ger, Frankfurt<br />
High-resolution immunogenetic monitor<strong>in</strong>g of the<br />
tcr repertoire<br />
Eliana Ruggiero, Heidelberg<br />
Establishment of the reversible peptide-Major Histocompatibility<br />
Complex (pMHC) class I Histamer technology: tool for visualization<br />
<strong>and</strong> selection of functionally active antigen-specific CD8+ T<br />
lymphocytes<br />
Sab<strong>in</strong>e Tischer, Hannover<br />
Lig<strong>and</strong> b<strong>in</strong>d<strong>in</strong>g of the human activat<strong>in</strong>g natural killer cell receptor<br />
NKp30 depends on its stalk doma<strong>in</strong> <strong>and</strong> the glycosylation<br />
status<br />
Jessica Hartmann, Frankfurt<br />
Potency <strong>and</strong> GMP development of SmartDC-TRP2: lentiviral<br />
vector-<strong>in</strong>duced dendritic cells for melanoma immunotherapy<br />
Renata Stripecke, Hannover<br />
18:30 - 19:30 DG-GT <strong>Gene</strong>ral Assembly HZ 3<br />
18:30 - 20:00 Poster View + Dr<strong>in</strong>ks<br />
20:00 SPECIAL SCIENCE NIGHT Saal West<br />
Young Scientists Meet the Speakers dur<strong>in</strong>g D<strong>in</strong>ner<br />
24
Change language